How much is EV Biotech worth in 2025?

EV Biotech has a current valuation of N/A based on their Secondary Transaction - Private round and secondary market data.

How much funding has EV Biotech raised?

EV Biotech has raised $5.8M in total funding across 0 funding rounds.

EV Biotech

Website

Last updated: N/A

Current Valuation

N/A

Total Funding Raised

$5.8M

Last Round

Secondary Transaction - Private

Amount undisclosed

Last Funding

Unknown

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

EV Biotech is currently valued at N/A. The company has raised a total of $5.8M in funding.

Investment Perspective

EV Biotech's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track EV Biotech Valuation Updates

Get notified when EV Biotech raises new funding or valuation changes

Explore More Data

Detailed analysis for EV Biotech

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

What is EV Biotech Worth in 2025?

As of 2025, EV Biotech is valued at N/A. This valuation positions EV Biotech as one of the leading private companies in the sector.

EV Biotech Valuation History

EV Biotech's funding history demonstrates steady growth and investor confidence.

How EV Biotech Valuation is Determined

Private company valuations like EV Biotech's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

Revenue growth and financial performance
Market opportunity and total addressable market (TAM)
Competitive positioning and market share
Management team strength and execution capability
Technology and intellectual property
Industry trends and investor sentiment

EV Biotech Valuation FAQs

Is EV Biotech profitable?

EV Biotech has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does EV Biotech's valuation compare to competitors?

EV Biotech is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will EV Biotech IPO?

EV Biotech has not announced plans for an initial public offering. Until an IPO, investors can access EV Biotech shares through secondary market platforms.